Lin, C., von der Thüsen, J., Daalhuisen, J., ten Brink, M., Crestani, B., van der Poll, T., . . . Spek, C. A. (2015). Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. Mol Med.

Lin, Cong, Jan von der Thüsen, Joost Daalhuisen, Marieke ten Brink, Bruno Crestani, Tom van der Poll, Keren Borensztajn, and C Arnold Spek. "Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection From Bleomycin-Induced Pulmonary Fibrosis." Mol Med 2015.

Lin, Cong, et al. "Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection From Bleomycin-Induced Pulmonary Fibrosis." Mol Med 2015.